Home

för att inte tala om Motsvarande möjlighet cd38 cell marker medborgarskap dumpa kolla upp

Cells | Free Full-Text | CD38, a Receptor with Multifunctional Activities:  From Modulatory Functions on Regulatory Cell Subsets and Extracellular  Vesicles, to a Target for Therapeutic Strategies
Cells | Free Full-Text | CD38, a Receptor with Multifunctional Activities: From Modulatory Functions on Regulatory Cell Subsets and Extracellular Vesicles, to a Target for Therapeutic Strategies

Unraveling B cell trajectories at single cell resolution: Trends in  Immunology
Unraveling B cell trajectories at single cell resolution: Trends in Immunology

CD38 - Wikipedia
CD38 - Wikipedia

Frontiers | CD38: An Immunomodulatory Molecule in Inflammation and  Autoimmunity
Frontiers | CD38: An Immunomodulatory Molecule in Inflammation and Autoimmunity

Human CD38 Antibody MAB24041: R&D Systems
Human CD38 Antibody MAB24041: R&D Systems

Cells | Free Full-Text | The Many Facets of CD38 in Lymphoma: From  Tumor–Microenvironment Cell Interactions to Acquired Resistance to  Immunotherapy
Cells | Free Full-Text | The Many Facets of CD38 in Lymphoma: From Tumor–Microenvironment Cell Interactions to Acquired Resistance to Immunotherapy

Cells | Free Full-Text | Novel Insights in Anti-CD38 Therapy Based on CD38-Receptor  Expression and Function: The Multiple Myeloma Model
Cells | Free Full-Text | Novel Insights in Anti-CD38 Therapy Based on CD38-Receptor Expression and Function: The Multiple Myeloma Model

Clinical significance of CD38 and CD101 expression in PD‑1+CD8+ T cells in  patients with epithelial ovarian cancer
Clinical significance of CD38 and CD101 expression in PD‑1+CD8+ T cells in patients with epithelial ovarian cancer

CD38, A Target for Immunotherapeutic Approaches in Cancer
CD38, A Target for Immunotherapeutic Approaches in Cancer

Clonally diverse CD38+HLA-DR+CD8+ T cells persist during fatal H7N9 disease  | Nature Communications
Clonally diverse CD38+HLA-DR+CD8+ T cells persist during fatal H7N9 disease | Nature Communications

CD38 is expressed selectively during the activation of a subset of mature T  cells with reduced proliferation but improved potential to produce  cytokines - Sandoval‐Montes - 2005 - Journal of Leukocyte Biology -
CD38 is expressed selectively during the activation of a subset of mature T cells with reduced proliferation but improved potential to produce cytokines - Sandoval‐Montes - 2005 - Journal of Leukocyte Biology -

International Clinical Cytometry Society
International Clinical Cytometry Society

Co-Expression of Positive Activation Marker CD38 and Negative or Exhaustion  Marker PD-1 in CD8+ T Cells | Biocompare.com Kit/Reagent Review
Co-Expression of Positive Activation Marker CD38 and Negative or Exhaustion Marker PD-1 in CD8+ T Cells | Biocompare.com Kit/Reagent Review

Alteration of Cell Surface Markers CD38 and CD138 in Lymphoproliferative  Disorders in the Ocular Adnexa | Anticancer Research
Alteration of Cell Surface Markers CD38 and CD138 in Lymphoproliferative Disorders in the Ocular Adnexa | Anticancer Research

DP T cells show markers of activation. (A-C) CD38 expression by CD4,... |  Download Scientific Diagram
DP T cells show markers of activation. (A-C) CD38 expression by CD4,... | Download Scientific Diagram

CD38 in the age of COVID-19: a medical perspective | Physiological Reviews
CD38 in the age of COVID-19: a medical perspective | Physiological Reviews

CD38 and Regulation of the Immune Response Cells in Cancer
CD38 and Regulation of the Immune Response Cells in Cancer

Cells | Free Full-Text | Mechanisms of Resistance to Anti-CD38 Daratumumab  in Multiple Myeloma
Cells | Free Full-Text | Mechanisms of Resistance to Anti-CD38 Daratumumab in Multiple Myeloma

CD38, A Target for Immunotherapeutic Approaches in Cancer
CD38, A Target for Immunotherapeutic Approaches in Cancer

Frontiers | CD38: A Significant Regulator of Macrophage Function
Frontiers | CD38: A Significant Regulator of Macrophage Function

Pathology Outlines - CD38
Pathology Outlines - CD38

Hematopoietic Stem Cell Marker (CD34, CD59, CD90 / Thy1, CD38, c-Kit)  Antibody Panel - Human (ab254022)
Hematopoietic Stem Cell Marker (CD34, CD59, CD90 / Thy1, CD38, c-Kit) Antibody Panel - Human (ab254022)